156 related articles for article (PubMed ID: 36627757)
1. An optimized radiosynthesis of [
Holt DP; Kumar D; Nimmagadda S; Dannals RF
J Labelled Comp Radiopharm; 2023 Feb; 66(2):47-54. PubMed ID: 36627757
[TBL] [Abstract][Full Text] [Related]
2. An improved radiosynthesis of [
Holt DP; Dannals RF
J Labelled Comp Radiopharm; 2022 Oct; 65(12):302-308. PubMed ID: 36000273
[TBL] [Abstract][Full Text] [Related]
3. An optimized radiosynthesis of [
Azad BB; Holt DP; Ravert HT; Horti AG; Dannals RF
J Labelled Comp Radiopharm; 2018 Jun; 61(7):567-572. PubMed ID: 29529708
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive PD-L1 quantification using [
Mishra A; Gupta K; Kumar D; Lofland G; Sharma AK; Solnes LB; Rowe SP; Forde PM; Pomper MG; Gabrielson EW; Nimmagadda S
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793856
[TBL] [Abstract][Full Text] [Related]
5. Development of [
Lesniak WG; Mease RC; Chatterjee S; Kumar D; Lisok A; Wharram B; Kalagadda VR; Emens LA; Pomper MG; Nimmagadda S
Mol Imaging; 2019; 18():1536012119852189. PubMed ID: 31187691
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Imaging of the Programmed Death Ligand 1 by
González Trotter DE; Meng X; McQuade P; Rubins D; Klimas M; Zeng Z; Connolly BM; Miller PJ; O'Malley SS; Lin SA; Getty KL; Fayadat-Dilman L; Liang L; Wahlberg E; Widmark O; Ekblad C; Frejd FY; Hostetler ED; Evelhoch JL
J Nucl Med; 2017 Nov; 58(11):1852-1857. PubMed ID: 28588151
[TBL] [Abstract][Full Text] [Related]
8. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
[TBL] [Abstract][Full Text] [Related]
9. cGMP production of the radiopharmaceutical [
Collier TL; Yokell DL; Livni E; Rice PA; Celen S; Serdons K; Neelamegam R; Bormans G; Harris D; Walji A; Hostetler ED; Bennacef I; Vasdev N
J Labelled Comp Radiopharm; 2017 May; 60(5):263-269. PubMed ID: 28185305
[TBL] [Abstract][Full Text] [Related]
10. Automated synthesis of (R)-[
Rosenberg AJ; Cheung YY; Liu F; Peterson TE; Silverman J; Considine CM; Claassen DO
J Labelled Comp Radiopharm; 2022 Jun; 65(8):223-229. PubMed ID: 35491085
[TBL] [Abstract][Full Text] [Related]
11. An automated radiosynthesis of (S)-[
Xie JK; Zhu XX; Wang KX; Wang SC; Xie Q
Appl Radiat Isot; 2021 Aug; 174():109740. PubMed ID: 33940354
[No Abstract] [Full Text] [Related]
12. Radiosynthesis and validation of [5-cyano-N-(4-(4-[
Mathews WB; Wu Y; Horti AG; Naik R; Hall AW; Holt DP; Dannals RF
J Labelled Comp Radiopharm; 2019 Nov; 62(13):903-908. PubMed ID: 31524293
[TBL] [Abstract][Full Text] [Related]
13. Automated radiosynthesis of the adenosine A
Lai TH; Wenzel B; Moldovan RP; Brust P; Kopka K; Teodoro R
J Labelled Comp Radiopharm; 2022 May; 65(6):162-166. PubMed ID: 35288969
[TBL] [Abstract][Full Text] [Related]
14. Automated radiosynthesis of [
Hird M; Russell JJ; Corrigan LL; Boros I; Nordeman P; Antoni G; Gurnell M; Aigbirhio FI
J Labelled Comp Radiopharm; 2024 Feb; 67(2):67-75. PubMed ID: 38116667
[TBL] [Abstract][Full Text] [Related]
15. Robust and Facile Automated Radiosynthesis of [
Edwards R; Greenwood HE; McRobbie G; Khan I; Witney TH
Mol Imaging Biol; 2021 Dec; 23(6):854-864. PubMed ID: 34013395
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and validation of [
Pereira MP; Tejería ME; Zeni M; Gambini JP; Duarte P; Rey A; Giglio J
J Labelled Comp Radiopharm; 2022 Aug; 65(10-11):292-297. PubMed ID: 35996821
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and validation of [Carboxy-
Holt DP; Kalinda AS; Bambarger LE; Jain SK; Dannals RF
J Labelled Comp Radiopharm; 2019 Jan; 62(1):28-33. PubMed ID: 30089334
[TBL] [Abstract][Full Text] [Related]
18. Promising potential of a
Lv G; Miao Y; Chen Y; Lu C; Wang X; Xie M; Qiu L; Lin J
Bioorg Chem; 2021 Oct; 115():105294. PubMed ID: 34426150
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Kumar D; Mishra A; Lisok A; Kureshi R; Shelake S; Plyku D; Sen R; Doucet M; De Silva RA; Mease RC; Forde PM; Jaffee EM; Desai P; Ganguly S; Gabrielson E; Vaidya D; Spangler JB; Nimmagadda S
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34508005
[TBL] [Abstract][Full Text] [Related]
20. One-step radiosynthesis and initial evaluation of a small molecule PET tracer for PD-L1 imaging.
Miao Y; Lv G; Chen Y; Qiu L; Xie M; Lin J
Bioorg Med Chem Lett; 2020 Dec; 30(24):127572. PubMed ID: 32979488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
